A Randomized, Open labelled, Active-controlled, Prospective Clinical Study to Evaluate Efficacy and Safety of Diabic Care Juice in Type 2 Diabetic Patients - NI

Mr Shrawan Daga0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•1.Patients on insulin therapy
•2.Patients suffering from Type-1 DM or Type of Diabetes mellitus other than Type-2
•3.Patients with known history of major complications of Diabetes like Keto-acidosis, Nephropathy, Neuropathy, Retinopathy and Diabetic wounds
•4.Patients with known history of chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C or HIV
•5.Patients with known history of active metabolic or gastrointestinal diseases that may interfere with nutrient absorption, metabolism, or excretion, excluding diabetes
•6.Patients with known history of chronic hepatic or renal disease
•7.Patients with known history of active malignancy
•8.Patients with known history of significant cardiovascular event at least 12 weeks prior to randomization.
•9.Known history of hypersensitivity to ingredients used in study drug
•10.Pregnant and Lactating females
•11.Any other conditions which in the opinion of investigator can place the patient at risk or can have influenced the conduct of study or interpretation of results

发起方

Mr Shrawan Daga